Plandai Biotechnology Inc (PLPL)

[Aston Martin]

Norbil, I would not hold if I would not believe since 2012. But on the other hand Plandai is going to behave like many microcaps: They deliver releases which all sound wonderful - but the stockmarket wants revenues and promises which are kept. Plandai has to show and to deliver what companies have to show to receive confidence. As long as Plandai does not deliver as long this story has limited value and is build on sand. By< the way: We do not know at all of Plandai will make 30.000.000 per year with Pythofare or tea extract etc. in 2016 even. So the marketcap is very 'ambitioned' taking into account that Plandai is in delay since 2012 and does nothing yet but dilution and debt - enormous debt by the way compared to the tiny revenues of just $ 130k in 4th quarter of 2013 !

Plandai has some nice things to show: Shively, a farm, thousands of acres of tea plants, connection with Pellicier, first results of clinical trials, etc. - but for a stable shareprice at this stage this is by far weak.

However, the story is better than many others but management does not need any shares - their bank account looks different than ours! For them Plandai is just a game, payed by the bank of Africa eetc. If Plandai fails - they lose nothing - but we losse possible a lot! Thats the price for speculation - if done wrong. But the small ones always pay the big ones